Literature DB >> 23852762

Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than Coronary Artery Calcification Score to detect subclinical atherosclerosis in patients with rheumatoid arthritis.

Alfonso Corrales1, José A Parra, Carlos González-Juanatey, Javier Rueda-Gotor, Ricardo Blanco, Javier Llorca, Miguel A González-Gay.   

Abstract

OBJECTIVE: To determine the ability of Coronary Artery Calcification Score (CACS) and carotid ultrasonography in detecting subclinical atherosclerosis in rheumatoid arthritis (RA).
METHODS: A set of 104 consecutive RA patients without history of cardiovascular (CV) events were studied to determine CACS, carotid intima-media thickness (cIMT) and plaques. Systematic Coronary Risk Evaluation (SCORE) modified according to the EULAR recommendations (mSCORE) was also assessed.
RESULTS: The mean disease duration was 10.8 years, 72.1% had rheumatoid factor and/or anti-CCP positivity and 16.4% extra-articular manifestations. Nine were excluded because they had type 2 diabetes mellitus or chronic kidney disease. CV risk was categorised in the remaining 95 RA patients according to the mSCORE as follows: low (n=21), moderate (n=60) and high/very high risk (n=14). Most patients with low mSCORE (16/21; 76.2%) had normal CACS (zero), and none of them CACS>100. However, a high number of patients with carotid plaques was disclosed in the groups with CACS 0 (23/40; 57.5%) or CACS 1-100 (29/38; 76.3%). 72 (75.8%) of the 95 patients fulfilled definitions for high/very high CV as they had an mSCORE ≥5% or mSCORE <5% plus one of the following findings: severe carotid ultrasonography findings (cIMT>0.9 mm and/or plaques) or CACS>100. A CACS>100 showed sensitivity similar to mSCORE (23.6% vs 19.4%). In contrast, the presence of severe carotid ultrasonography findings allowed identifying most patients who met definitions for high/very high CV risk (70/72; sensitivity 97.2% (95% CI 90.3 to 99.7)).
CONCLUSIONS: Carotid ultrasonography is more sensitive than CACS for the detection of subclinical atherosclerosis in RA.

Entities:  

Keywords:  Atherosclerosis; Cardiovascular Disease; Rheumatoid Arthritis; Ultrasonography

Mesh:

Year:  2013        PMID: 23852762     DOI: 10.1136/annrheumdis-2013-203688

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  39 in total

1.  Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis.

Authors:  Inmaculada del Rincón; Joseph F Polak; Daniel H O'Leary; Daniel F Battafarano; John M Erikson; Jose F Restrepo; Emily Molina; Agustín Escalante
Journal:  Ann Rheum Dis       Date:  2014-05-20       Impact factor: 19.103

2.  Impact of Changes in Inflammation on Estimated Ten-Year Cardiovascular Risk in Rheumatoid Arthritis.

Authors:  Zhi Yu; Nicole Yang; Brendan M Everett; Michelle Frits; Christine Iannaccone; Jonathan Coblyn; Michael Weinblatt; Nancy Shadick; Daniel H Solomon; Katherine P Liao
Journal:  Arthritis Rheumatol       Date:  2018-08-01       Impact factor: 10.995

Review 3.  Cardiovascular risk in patients with rheumatoid arthritis.

Authors:  Kim Lauper; Cem Gabay
Journal:  Semin Immunopathol       Date:  2017-04-28       Impact factor: 9.623

4.  Subclinical Carotid Atherosclerosis in COPD Cases and Control Smokers: Analysis in Relation with COPD Exacerbations and Exacerbation-like Episodes.

Authors:  Rafael Golpe; Alfonso Mateos-Colino; Carlos González-Juanatey; Ana Testa-Fernández; Nuria Domínguez-Pin; Francisco J Martín-Vázquez
Journal:  Lung       Date:  2017-02-24       Impact factor: 2.584

5.  Can the ankle brachial pressure index (ABPI) and carotis intima media thickness (CIMT) be new early stage markers of subclinical atherosclerosis in patients with rheumatoid arthritis?

Authors:  Tolga Kurt; Ahmet Temiz; Ferhat Gokmen; Gurhan Adam; Sedat Ozcan; Ersan Ozbudak; Mustafa Sacar
Journal:  Wien Klin Wochenschr       Date:  2015-03-17       Impact factor: 1.704

6.  Subclinical atherosclerosis in systemic lupus erythematosus patients and its relationship to disease activity and damage indices.

Authors:  S Fadda; H Nassar; S M Gamal; H Al-azizi
Journal:  Z Rheumatol       Date:  2015-08       Impact factor: 1.372

Review 7.  Sex and Cardiovascular Involvement in Inflammatory Joint Diseases.

Authors:  Santos Castañeda; Carlos González-Juanatey; Miguel A González-Gay
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

Review 8.  Lipid-lowering Therapies in Myositis.

Authors:  Marisa C Mizus; Eleni Tiniakou
Journal:  Curr Rheumatol Rep       Date:  2020-08-26       Impact factor: 4.592

9.  The role of interleukin-6 trans-signalling on cardiovascular dysfunction in inflammatory arthritis.

Authors:  Ruth Davies; Jessica Williams; Katie Sime; Hyun-Sun Jin; Charlotte Thompson; Lauren Jordan; Derek Lang; Julian P Halcox; Elizabeth Ellins; Gareth W Jones; Simon A Jones; Stefan Rose-John; Anwen Williams; Ernest Choy
Journal:  Rheumatology (Oxford)       Date:  2021-06-18       Impact factor: 7.580

10.  Accelerated atherosclerosis in premenopausal women with rheumatoid arthritis - 15-year follow-up.

Authors:  Metka Koren Krajnc; Radovan Hojs; Iztok Holc; Željko Knez; Artur Pahor
Journal:  Bosn J Basic Med Sci       Date:  2021-08-01       Impact factor: 3.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.